Prévisions du marché de l’immunohistochimie en Asie-Pacifique jusqu’en 2028 – Impact du COVID-19 et analyse régionale par application (diagnostics et tests de médicaments), produit (anticorps, équipement, réactifs et kits) et utilisateur final (hôpitaux et laboratoires de diagnostic, instituts de recherche et autres )

Introduction au marché

L\'APAC est le marché régional de l\'immunohistochimie qui connaît la croissance la plus rapide ; et la Chine, l’Inde, le Japon, la Corée du Sud, l’Australie et le reste de l’APAC sont les principaux contributeurs au marché de cette région. La Chine a dominé le marché en 2021. La croissance du marché est attribuée à l\'augmentation des activités de R&D, à l\'augmentation des investissements dans le secteur de la santé dans les pays en développement et à l\'augmentation des collaborations entre l\'externalisation de la réglementation et les développeurs de médicaments. Les acteurs du marché lancent des produits. Par exemple, en août 2020, Gilead Sciences Inc. a reçu l’approbation du Truvada, un médicament de prévention du VIH destiné à être utilisé en médecine chez les adultes et les adolescents en Chine. Cette approbation contribuera à prévenir le VIH parmi la population en bonne santé. De nombreuses maladies infectieuses émergent, réapparaissent ou provoquent des épidémies récurrentes dans la région Asie-Pacifique. Les personnes voyageant plus fréquemment, vivant dans des zones plus densément peuplées et entrant en contact plus étroit avec des animaux sauvages, ont accru le risque de propagation rapide des maladies infectieuses émergentes. La situation actuelle du COVID-19 a également accru la surveillance du virus de la grippe au sein de la population afin d’améliorer le diagnostic de la maladie. Selon la Commission nationale de la santé (NHC) de Chine, au 26 mars 2020, 81 285 cas d\'infection à coronavirus ont été signalés en Chine, avec un total de 3 287 décès dus à l\'épidémie. La maladie s\'est transmise à un rythme rapide dans les phases initiales. Cependant, la prévalence de maladies dues à différentes infections virales telles que le virus Rotavirus, le virus de l’hépatite AE, le virus de la Dengue et d’autres devraient également stimuler le marché au cours de la période de prévision. Ceci, l’augmentation des maladies infectieuses émergentes, l’amélioration des capacités de diagnostic et l’augmentation des programmes gouvernementaux concernant une meilleure compréhension des maladies virales devraient stimuler la croissance du marché de l’immunohistochimie dans les années à venir.

Les pays de la région APAC, en particulier l’Inde, sont fortement touchés par l’épidémie de COVID-19. Les perturbations de la chaîne d’approvisionnement et l’énorme demande de traitements efficaces pour le traitement du COVID-19 ont placé le secteur de la recherche en soins de santé dans une situation cruciale en APAC. Des mesures prohibitives ont été prises pour contrôler la propagation du nouveau coronavirus. La pandémie de COVID-19 a eu des répercussions négatives sur les économies de la région. La situation socio-économique a été gravement affectée, avec une inflation négative, un PIB négatif et une hausse du chômage régional. Des pays comme la Chine, le Japon, Singapour et la Corée du Sud constatent un intérêt croissant pour les essais cliniques. Les coûts élevés dans les pays occidentaux contribuent également au flux de sous-traitance des affaires médicales vers l’APAC. Pour accroître leurs ventes sur le marché asiatique, les sociétés pharmaceutiques prennent conscience des environnements réglementaires nouveaux et changeants pour les médicaments, les dispositifs et les diagnostics in vitro. Des réglementations nouvelles ou améliorées sont fréquemment mises en œuvre en Asie, notamment des modifications des normes BPF, des contrôles des prix des médicaments et des systèmes de réglementation des dispositifs médicaux. Des orientations et des conseils de tiers sont requis dans le cadre de toute acquisition ou de toute amélioration des normes actuelles. De plus en plus, les prestataires de services d\'externalisation tiers jouent un rôle important dans le soutien du marché associé dans la région APAC. Cependant, le marché s\'est stabilisé par rapport aux phases initiales de la pandémie grâce aux procédures de contrôle, à la sensibilisation de la population, à la disponibilité des vaccins et aux politiques gouvernementales de soutien aux entreprises sur le marché concerné.

< u>Aperçu et dynamique du marché

Le marché de l\'immunohistochimie de l\'APAC devrait passer de 483,76 millions de dollars US en 2021 à 818,00 millions de dollars US d\'ici 2028 ; on estime qu\'il augmentera à un TCAC de 7,8 % de 2021 à 2028. L\'immunohistochimie (IHC) fait référence à une application importante des anticorps monoclonaux et polyclonaux pour la détermination tissulaire et la distribution d\'antigènes d\'une maladie particulière. Il est principalement utilisé pour détecter plusieurs maladies infectieuses comme la dengue, l\'hépatite et le virus de l\'immunodéficience humaine (VIH). Les maladies chroniques telles que l’obésité, le cancer, le diabète, les maladies cardiaques et les accidents vasculaires cérébraux sont également considérées comme les principales applications majeures de l’immunohistochimie qui facilitent le diagnostic de ces maladies. Le diabète prévaut à un taux élevé dans la population gériatrique de la région. La prévalence du diabète touche davantage les personnes en surpoids et obèses. Les taux d’obésité ont augmenté rapidement dans les économies développées et en développement de la région. Des facteurs tels qu’un mode de vie malsain et la vie sédentaire sont parmi les principaux responsables de l’augmentation du nombre de personnes obèses. Les maladies cardiovasculaires (MCV) comprennent les maladies cérébrovasculaires, les cardiopathies rhumatismales, les maladies coronariennes et d\'autres affections. C’est la cause la plus importante de morbidité et de mortalité dans la région. En outre, l’incidence du cancer et les taux de mortalité ont augmenté dans toute la région, faisant du cancer la principale cause de décès. Une telle augmentation de l\'incidence des maladies chroniques et infectieuses devrait créer une demande de tests d\'immunoessai dans la région APAC.

Segments clés du marché

En termes de produit, le segment des anticorps représentait la plus grande part du marché de l’immunohistochimie APAC en 2020. En termes d’application, le segment des diagnostics détenait une part de marché plus importante du marché de l’immunohistochimie APAC en 2020. De plus, le segment des hôpitaux et des laboratoires de diagnostic détenait une part plus importante du marché de l\'immunohistochimie de l\'APAC en fonction de l\'utilisateur final en 2020.

Principales sources et sociétés répertoriées

Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché de l\'immunohistochimie de l\'APAC sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents du gouvernement national et les bases de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont Abcam plc ; Agilent Technologies, Inc. ; Bio SB ; LABORATOIRES BIO-RAD INC.; Technologie de signalisation cellulaire, Inc. ; Danaher ; F. HOFFMANN-LA ROCHE LTÉE; MERCK KGaA ; PerkinElmer Inc. ; et THERMO FISHER SCIENTIFIC INC.

Rapport sur les raisons d\'acheter

Comprendre le paysage du marché de l\'immunohistochimie de l\'APAC et identifier les segments de marché les plus susceptibles de garantir un rendement important
Gardez une longueur d\'avance sur la course en comprenant les changements en constante évolution paysage concurrentiel pour le marché de l\'immunohistochimie APAC
Planifier efficacement les fusions et acquisitions et les accords de partenariat sur le marché de l\'immunohistochimie APAC en identifiant les segments de marché avec les ventes probables les plus prometteuses
Aide à prendre des décisions commerciales éclairées de manière perspicace et une analyse complète des performances du marché de divers segments du marché de l\'immunohistochimie APAC
Obtenez les prévisions de revenus du marché pour le marché par divers segments de 2021 à 2028 dans la région APAC.

Segmentation du marché de l\'immunohistochimie APAC

Marché de l\'immunohistochimie APAC - Par produit

Équipement
- Systèmes de coloration de lames
- Systèmes de micropuces de tissus
- Systèmes de traitement des tissus
- Scanners de lames
- Autres équipements
Anticorps
- Anticorps primaires
- Anticorps secondaires
Réactifs
- Colorations histologiques
- Réactifs de blocage et de fixation
- Substrats chromogènes
- Réactifs de fixation
- Stabilisants
- Solvants organiques
- Enzymes protéolytiques
- Diluants
Kits

Marché de l\'immunohistochimie APAC - Par application

Diagnostic
- Cancer
- Maladies infectieuses
- Maladies auto-immunes
- Diabète sucré
- Maladies néphrologiques
- Autres
Dépistage de drogues

Marché de l\'immunohistochimie APAC - Par utilisateur final

Hôpitaux et laboratoires de diagnostic
Instituts de recherche
Autres

Marché de l\'immunohistochimie APAC – Par pays

Marché de l\'immunohistochimie APAC - Profils d\'entreprises

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Immunohistochemistry Market – By Product

1.3.2 APAC Immunohistochemistry Market – By Application

1.3.3 APAC Immunohistochemistry Market – By End User

1.3.4 APAC Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalating Incidences of Chronic and Infectious Diseases

5.1.2 Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complications Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Burgeoning Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Growing Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – APAC Analysis

6.1 APAC Immunohistochemistry Market Revenue Forecast and Analysis

7. APAC Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Immunohistochemistry Market – Country Analysis

10.1 APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.2 APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3 India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42. Organic Developments Done By Companies

Table 43. Inorganic developments done by Companies

Table 44. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Immunohistochemistry Market Segmentation

Figure 2. APAC Immunohistochemistry Market Segmentation, By Country

Figure 3. APAC Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8. APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43. APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample